Investigating genetic variations in cancer risk and outcomes for African Americans
Official title: Core 1
Funded at Wayne State University · NIH-11034099 · Data updated 2026-11-12
This study is looking at how genetic differences can influence cancer risk and recovery, especially for African Americans, and if you join, you might also get the chance to have genetic testing that could help with your treatment.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project start | February 13, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $654,206 |
| NIH project number | 5P01CA272239-02 |
| Project ID | NIH-11034099 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include African American individuals with a history of cancer or those interested in genetic testing related to cancer risk.
✕Less likely to help
Patients who do not identify as African American or those without a history of cancer may not benefit from this research.
What this research studies
This research focuses on understanding how genetic variations affect cancer risk and outcomes specifically in African American populations. It utilizes a shared platform to identify eligible participants from the Detroit Research on Cancer Survivors (ROCS) study, collecting and managing genetic data and biospecimens. The study aims to link patient data with cancer registry information to provide insights into cancer recurrence and survival outcomes. Participants may also receive access to clinical genetics testing for actionable mutations.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer risk assessment and personalized treatment options for African American patients.
How similar studies have gone: Previous research has shown success in utilizing genetic data to improve cancer outcomes, particularly in diverse populations, indicating a promising approach.
Where this research is happening
-
Wayne State University
Detroit, United States Active
Researchers
- Principal investigator: Schwartz, Ann G. — Wayne State University
- Study coordinator: Schwartz, Ann G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.